Primary Plasma Cell Leukaemia (pPCL) Pada Sumsum Tulang Belakang: Laporan Kasus dan Tinjauannya

Authors

  • Indah Afriwanty Simatupang Institut Kesehatan Helvetia
  • Fahmi Irsan Nasution Institut Kesehatan Helvetia
  • Hendri Meirialdi Institut Kesehatan Helvetia

DOI:

https://doi.org/10.57214/jasira.v3i4.258

Keywords:

Anemia, Bone Marrow Aspiration, Multiple Myeloma, Peripheral Blood, Plasma Cell Leukemia

Abstract

Plasma Cell Leukemia (PCL) is a rare lymphoproliferative disorder characterized by the proliferation of malignant plasma cells in the bone marrow and their presence in the peripheral blood. PCL is classified into primary plasma cell leukemia (pPCL), which occurs de novo without a prior history of multiple myeloma, and secondary plasma cell leukemia (sPCL), which arises in association with relapsed or refractory multiple myeloma. A 58-year-old woman presented with right hip pain that had been ongoing for four months. The pain progressively worsened, limiting her ability to move her leg and eventually causing significant difficulty in walking. She also experienced bilateral lower limb weakness and an unintentional weight loss of 10 kg over the same period. The patient denied any history of trauma. Physical examination revealed pallor without signs of bruising or spontaneous bleeding. Laboratory findings showed severe anemia (Hb 6.5 g/dL), leukocytosis (24,100/µL), thrombocytopenia, an elevated erythrocyte sedimentation rate, and 25% plasma cells on peripheral blood smear. Bone marrow aspiration demonstrated 40% infiltration by plasma cells. Based on the patient’s clinical presentation, physical examination, and laboratory findings, the diagnosis is consistent with primary Plasma Cell Leukemia.

References

Braga, C. G., Rodrigues, A. R., Alves, M., Portela, C., Pinto, L., & Marques, H. (2016). Plasma cell leukaemia. Porto Biomedical Journal, 1(2), 49–51. https://doi.org/10.1016/j.pbj.2016.04.001

Davies, F. E., & Anderson, K. C. (2011). Abnormalities in immunoglobulin synthesizing cells. In Blood and bone marrow pathology (2nd ed.). Elsevier. https://doi.org/10.1016/B978-0-7020-3147-2.00030-4

Fernández de Larrea, C., Kyle, R., Durie, B., Ludwig, H., Usmani, S., Vesole, D., Hajek, R., San Miguel, J., Sezer, O., Sonneveld, P., & Kumar, S. (2013). Plasma cell leukemia: Consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group. Leukemia, 27(4), 780–791. https://doi.org/10.1038/leu.2012.336

Fonseca, D., Ahmed, F., Murthy, S. S., & Rajappa, S. (2012). Plasma cell leukemia. International Journal of Pharma and Bio Sciences, 3(1), 1–9. https://www.researchgate.net/publication/259290488

Gonsalves, W. I., Rajkumar, S. V., Go, R. S., Dispenzieri, A., Gupta, V., Morice, W. G., & Kapoor, P. (2014). Survival trends in primary plasma cell leukemia: A single-center experience. Blood Cancer Journal, 4(7), e294. https://doi.org/10.1038/bcj.2014.53

Gundesen, M. T., Lund, T., Moeller, H. E. H., & Abildgaard, N. (2019). Plasma cell leukemia: Definition, presentation, and treatment. Current Oncology Reports, 21(1), 6. https://doi.org/10.1007/s11912-019-0754-x

H., D. S. (2017). Leukemia sel plasma primer. Jurnal Patologi, 29(3), 276–280. https://doi.org/10.21776/ub.jkb.2017.029.03.17

Jurczyszyn, A., Castillo, J. J., Avivi, I., Czepiel, J., Ferrero, S., Waszczuk-Gajda, A., & Sanchorawala, V. (2019). Clinical characteristics and outcomes of primary plasma cell leukemia: A multicenter study. Leukemia Research, 76, 62–67. https://doi.org/10.1016/j.leukres.2018.11.002

Katodritou, E., Terpos, E., Kastritis, E., Symeonidis, A. S., Pouli, A., Delimpasi, S., & Dimopoulos, M. A. (2018). Improved survival in primary plasma cell leukemia patients with novel agents. Haematologica, 103(12), e572–e575. https://doi.org/10.3324/haematol.2018.194373

Kyle, R. A., Child, J. A., Anderson, K., Barlogie, B., Bataille, R., Bensinger, W., Bladé, J., Boccadoro, M., Dalton, W., Dimopoulos, M., Djulbegovic, B., … Wheatley, K. (2003). Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: A report of the International Myeloma Working Group. British Journal of Haematology, 121(5), 749–757. https://doi.org/10.1046/j.1365-2141.2003.04355.x

Michaela, L., & Medeiros, B. C. (2010). Plasma cell leukemia: Concepts and management. Expert Review of Hematology, 3(1), 55–62.

Mina, R., D’Agostino, M., Cerrato, C., Gay, F., & Palumbo, A. (2017). Plasma cell leukemia: Update on biology and therapy. Leukemia & Lymphoma, 58(7), 1538–1547. https://doi.org/10.1080/10428194.2016.1250263

Musto, P., Simeon, V., Todoerti, K., & Neri, A. (2016). Primary plasma cell leukemia: Identity card 2016. Current Treatment Options in Oncology, 17(4), 20. https://doi.org/10.1007/s11864-016-0392-6

Nagtegaal, I. D., Odze, R. D., Klimstra, D., Paradis, V., Rugge, M., Schirmacher, P., Washington, M. K., Carneiro, F., & Cree, I. A. (2017). WHO classification of tumours of haematopoietic and lymphoid tissues (4th ed.). IARC Press.

Pagano, L., Valentini, C. G., Grammatico, S., & Pulsoni, A. (2016). Primary plasma cell leukemia: A systematic review. Clinical Lymphoma, Myeloma & Leukemia, 16(8), 417–421. https://doi.org/10.1016/j.clml.2016.05.011

Downloads

Published

2025-11-30

How to Cite

Indah Afriwanty Simatupang, Fahmi Irsan Nasution, & Hendri Meirialdi. (2025). Primary Plasma Cell Leukaemia (pPCL) Pada Sumsum Tulang Belakang: Laporan Kasus dan Tinjauannya. Jurnal Siti Rufaidah, 3(4), 181–189. https://doi.org/10.57214/jasira.v3i4.258

Similar Articles

<< < 1 2 3 

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)